{"Content: ":"The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Telangana. The first case was recorded in this region on 2 March from a man who had travel history with the UAE.[citation needed] [6] High Positivity Rate: Positivity Rate can be loosely defined as the number of patients turning positive for coronavirus upon testing per every 100 suspects. This rate can be calculated either on a daily basis or on a cumulative basis on the total number of tests conducted. In this parameter, Telangana state fares as one of the worst performing state in India with very high positivity rate. As per the health bulletin issued by Government of Telangana on June 30, Telangana state claims to have conducted a cumulative number of 88563 tests of which, 16339 tested positive. The overall positivity rate comes to 18.44% (applicable for up to June 30). It needs to be noted that for a long time, the Telangana state did not publicly disclose the daily number of tests it was conducting daily that drew the ire of the High Court.[9] Hence, the cumulative number of tests cannot be corroborated. The daily positivity rate for number of tests conducted by Telangana state on June 30 comes to 27.33%. On 30 June, the Telangana state conducted 3457 tests, out of which the positive cases were 945. As per Telangana government media bulletin dated 31-Jul-2020, number of testing facilities in the state are as below. Status of Tests in the state is as below.[10] As on 27 July, more than 60% of COVID-19 victims of the state had been buried in a single graveyard named Faqeer Mullah Kabristan on the outskirts of Hyderabad.[12] On January 1, 2021, the Drug Controller General of India, approved the emergency or conditional use of AstraZeneca's COVID-19 vaccine AZD1222 (marketed as Covishield).[13] Covishield is developed by the University of Oxford and its spin-out company, Vaccitech.[14] It's a viral vector vaccine based on replication-deficient Adenovirus that causes cold in Chimpanzees. It can be stored, transported and handled at normal refrigerated conditions (two-eight degrees Celsius/ 36-46 degrees Fahrenheit). It has a shelf-life of at least six months. On 12 January 2021 first batches of Covishield vaccine was despatched from the Serum Institute of India.[15] On January 2, 2021, BBV152 (marketed as Covaxin), first indigenous vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology received approval from the Drug Controller General of India for its emergency or conditional usage.[16] On 14 January 2021 first batches of Covaxin vaccine was despatched from the Bharat Biotech, albeit it was still in the third phase of testing.[17] On 19 May 2021, Dr Reddy's Labs received Emergency Use Authorisation for anti-COVID drug 2-DG.[18] On 21 February, 2022, Drugs Controller General of India granted approval to Biological E's COVID-19 vaccine Corbevax, that can be used for children between 12 and 18 years of age.[19][20] On 21 October 2021, India completed administering of one billion Covid vaccines in the country.[21] On 8 January 2022, India crossed 1.5 billion Covid vaccines milestone in the country.[22] On 19 February 2022, India crossed 1.75 billion Covid vaccines milestone in the country.[23] On 12 January 2021, a consignment of 3.64 lakh doses of Oxford-AstraZeneca's Covishield vaccine arrived in Hyderabad from Pune.[24] Along with 3.64 lakh doses of Covishield, manufactured by Serum Institute of India, the Telangana Health department has received 20,000 doses of Bharat Biotech's Covaxin on 13 January 2021.[25] S Kistamma, a female sanitation worker at the Gandhi Hospital in Secunderabad, became the first person in Telangana to receive the COVID-19 vaccination on the morning of 16 January 2020.[26]","Title":"COVID-19 pandemic in Telangana - Wikipedia","KeyID":"10425","URL":"https://en.wikipedia.org/wiki/COVID-19_pandemic_in_Telangana"}